Evaluation of Hematopoietic Stem Cell Mobilization Rates with Early Plerixafor Administration for Adult Stem Cell Transplantation
Author:
Publisher
Elsevier BV
Subject
Transplantation,Hematology
Reference16 articles.
1. The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies;Kessinger;Blood,1991
2. Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter?;Korbling;Blood,2001
3. Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma;DiPersio;Blood,2009
4. Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocytes stimulating factor for autologous stem cell mobilization and transplantation for patients with non-Hodgkin's lymphoma;DiPersio;J Clin Oncol,2009
5. Plerixafor plus granulocyte stimulating factor improves the mobilization of hematopoietic stem cells in patients with non-Hodgkin's lymphoma and low circulating peripheral blood CD34+ cells;Maziarz;Biol Blood Marrow Transplant,2013
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Autologous peripheral blood stem cell harvest timing by absolute neutrophil count in children and young adult patients: Single-institute experience;Pediatrics & Neonatology;2024-08
2. Evaluation of CD34+ Cell Count at Different Time Points Following Plerixafor Administration in Autologous Hematopoietic Stem Cell Transplantation;International Journal of Cancer Management;2022-08-20
3. Getting blood out of a stone: Identification and management of patients with poor hematopoietic cell mobilization;Blood Reviews;2021-05
4. Impact of Plerixafor Use at Different Peripheral Blood CD34+ Thresholds on Autologous Stem Cell Collection in Patients with Multiple Myeloma;Biology of Blood and Marrow Transplantation;2020-05
5. Evaluation of mobilization efficacy with an extended interval following plerixafor administration;Journal of Oncology Pharmacy Practice;2020-02-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3